ArticleSurgical endoscopy2025
The extracorporeal length of nasobiliary tube as a risk factor for nasobiliary tube migration.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Protrusion of nasobiliary drainage catheter through the anus.Gastroenterology report · 2026Article
- Predicting unplanned extubation risk in patients with endoscopic nasobiliary drainage.World journal of gastrointestinal surgery · 2025Article
- Current Perspectives on Endoscopic Nasobiliary Drainage: Optimizing Patient Management and Preventing Complications.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
BACKGROUND AND
aimEndoscopic nasobiliary drainage (ENBD) plays a crucial role in the treatment of acute cholangitis and obstructive jaundice. This research aimed to investigate the clinical characteristics and risk factors associated with nasobiliary drainage (NBD) tube migration.
methodsA retrospective single-center study was conducted, including all patients who underwent ERCP and placed an NBD tube between January 2022 and December 2023.
resultsA total of 1077 patients were included in this study (mean age 59.8 years). Among these, 75 (7.0%) experienced NBD tube migration during their hospital stay. Univariate analysis showed that the maximum width of the bile duct, type of NBD tube, bile duct stricture, placement of a bile stent and/or pancreatic duct stent, and the extracorporeal length of NBD tube were correlated with NBD tube migration (p < 0.05). Multivariate regression analysis indicated that the type of NBD tube (p = 0.01 OR 1.9, 95% CI (1.16-3.13)) and the extracorporeal length of the NBD tube (p < 0.0001 OR 0.96, 95% CI (0.96-0.99)) were independent risk factors for NBD tube migration. Furthermore, it was found that when the extracorporeal length of the NBD tube was greater than 150 cm, the incidence of NBD tube migration was significantly lower than in the group with lengths less than 150 cm (p < 0.001).
conclusionNBD tube migration is not uncommon in clinical practice. The type of NBD tube and the extracorporeal length of the NBD tube were identified as independent risk factors for NBD tube migration. Ensuring that the extracorporeal length of the NBD tube is greater than 150 cm may reduce the incident of NBD tube migration.
Indexed as
Identifiers
40047866What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.